The aim of the present study was to determine both susceptibility and resistance pattern among clinical isolates of Pseudomonas aeruginosa in order to make continuous monitoring to the action of antipseudomonal drug in Egypt and to initiate the treatment with the appropriate antibiotic to avoid failure of treatment due to resistance. A total of 104 clinical isolates were collected and identified as Pseudomonas aeruginosa from Mansoura University Hospitals. The isolates were tested for antimicrobial susceptibility against 10 different antibiotics by using disk diffusion method. Resistance rates for imipenem, piperacillin, amikacin, gentamicin and ciprofloxacin were found 19.23%, 20.19%, 24%, 26.92%, and 30.76%; respectively. Resistance rates to chloramphenicol, co-trimoxazole, ceftazidime and ceftriaxone were variable and reached up to 83.65%. Exceptionally all isolates were resistant to carbencillin (100%). Thirty-six (34.61%) of isolates were multi-drug resistant. Imipenem, piperacillin and amikacin were the most effective antimicrobial agents against Ps. aeruginosa clinical isolates. It is recommended by the health authority to limit the further increase of antimicrobial resistance among Ps. aeruginosa by declining the rational treatment regimen.
INTRODUCTION
Continuous survey for susceptibility pattern of Pseudomonas aeruginosa in Egypt geographical area is important to grade the antibiotic therapy and for developing resistance control. The present study aimed to determine the antibiotic susceptibility profile in level variable by Hospitals of Mansoura University.
Pseudomonas aeruginosa is a notorious opportunistic pathogen and is isolated mostly from patient with urinary tract infections, wound infections, and severe burns. Ps.aeruginosa has been considered a nosocomial pathogen in a number of studies. Ps.aeruginosa infections are also known to be a serious problem in hospitalized patients with cystic fibrosis, cancer and burns. Half of these infections are fatal. Those infections are problematic due to the bacterial resistance to antibiotic and disinfectants (Lambert, 2002) .
Proliferation and transmission of antimicrobial-resistant bacteria is accelerated by close contact between individuals in institutions such as hospitals, day care centers and military barracks (Goldmann, 1999) . The mobility of the world's populations also facilitates the rapid dissemination of microorganisms harboring antibiotic resistance genes (Goldmann, 1999) . The spread of antibiotic resistance within a hospital, country or globally is usually achieved by clones with a high transmission ability (Livermore, 2003) .
The evolution and spread of antibiotic resistance in bacteria is a complex process involving a variety of different mechanisms. Some bacterial species show a high intrinsic resistance to specific antibiotics, while susceptible bacteria may acquire resistance by alterations in their own genome via mutations or the transfer of resistance genes 
MATERIAL and METHODS

Bacterial isolates
One hundred and four non duplicate Ps. aeruginosa isolates were collected from Mansoura University hospitals, from different clinical samples (wound swab, burn swab, ear swab, endotracheal swab and urine), identified and verified by using the standard biochemical reactions according to Collee et al. (1996) . All isolates were collected under approved ethical procedures.
Antimicrobial Susceptibility testing
The susceptibility was determined by disk diffusion method according to CLSI (2006) 
RESULTS
Susceptibility patterns of Ps. aeruginosa to different antibiotics
Antimicrobial susceptibility pattern of Pseudomonas aeruginosa were varied markedly with the antibiotic tested. Highest resistance rates were found to carbencillin (100%) and the least resistance were found to imipenem (19.23% Figure  (1-2) . Multi-drug resistance (resistance to 3 or more different families of antibiotics tested) was found in 36 isolates (34.61%) of Ps. aeruginosa tested ( Table 2) . In the present study about 69.23% of Ps.aeruginosa isolates were resistant to ceftazidime (CAZ) which in agreement with Zafer et al. 2014 in Egypt which reported the resistance 60.6% and disagreement with that reported by Afifi et al. (2013) in Egypt where 19.5% of the isolates were resistant.
In the present study, the clinical isolates show high resistance against ceftriaxone, where 83.65% of isolates were resistant. This high resistance was in agreement with that reported by Afifi et al. In the present study, 24% of Ps.aeruginosa isolates were resistant to amikacin (AK), which was in agreement with that reported by Zafer et al. 2014 (32.8%), where 7.8 % of the isolates were reported resistant by Afifi et al.(2013) . High resistance was expressed by the same organisms in studies performed by Viren et al.(2008) 
